The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development process for industry and patients. Our two companies are applying AI in ...
As Artificial Intelligence (AI) becomes more popular in everyday life, drug research and development companies are incorporating it into their process. Dotmatics, an early research and development ...
Evan Feinberg founded Genesis Molecular AI seven years ago to take his research at Stanford on AI for drug discovery to the real world. Today the company announced its biggest partnership to date: A ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results